Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort

Parasite Immunology

Volumn 32, Issue 2, 2010, Pages 125-134

  Duah, N O ^a,b   Miles, D J C ^b,c   Whittle, H C ^b   Conway, D J ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Acquired immunity; Antibody isotypes; Birth cohort; Blood stage antigens; Plasmodium falciparum

Indexed keywords

ANTIBODY; ANTIGEN; APICAL MEMBRANE ANTIGEN 1; BLOOD GROUP ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MATERNAL ANTIBODY; MEASLES VACCINE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; MEROZOITE SURFACE PROTEIN 3; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY ISOLATION; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; BIRTH; CHILD; COHORT ANALYSIS; GAMBIA; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MEASLES; PASSIVE IMMUNIZATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; URBAN AREA; VERTICAL TRANSMISSION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GAMBIA; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN ISOTYPES; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 74549200999     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2009.01165.x     Document Type: Article

References (49)

1. McGregor IA. Demographic effects of malaria with special reference to the stable malaria in Africa. West Afr Med J 1960 9 : 260 265.
2. Riley EM, Wagner GE, Ofori MF, et al. Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun 2000 68 : 5856 5863.
3. Pasvol G, Weatherall DJ Wilson RJ. Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum. Nature 1977 270 : 171 173.
4. Edozien JC, Gilles HM Udeozo IOK. Adult and cord-blood gamma-globulin and immunity to malaria in Nigerians. Lancet 1962 ii : 951 955.
5. McGregor IA. Studies in the acquisition of immunity of Plasmodium falciparum infections in Africa. Trans R Soc Trop Med Hyg 1964 58 : 80 92.
6. Brabin B. Analysis of malaria parasite rates in infants: 40 years after McDonald. Trop Dis Bull 1990 87 : R1 R27.
7. Snow RW, Nahlen B, Palmer A, Donnelly CA, Gupta S Marsh K. Risk of severe malaria among African infants: direct evidence of clinical protection during early infancy. J Infect Dis 1998 177 : 819 822.
8. Kitua AY, Urassa H, Wechsler M, et al. Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perenial transmission: relationships with clinical malaria and with entomological innoculation rates. Parasite Immunol 1999 21 : 307 317.
9. Achidi EA, Salimonu LS, Perlmann H, Perlmann P, Berzins K Williams AI. Lack of association between levels of transplacentally acquired Plasmodium falciparum-specific antibodies and age of onset of clinical malaria in infants in a malaria endemic area of Nigeria. Acta Trop 1996 61 : 315 326.
10. Branch OH, Udhayakumar V, Hightower AW, et al. A longitudinal investigation of IgG and IgM antibody responses to merozoite surface protein-119 kDa domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitaemia and anemia. Am J Trop Med Hyg 1998 58 : 211 219.
11. Taylor RR, Allen SJ, Greenwood BM Riley EM. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg 1998 58 : 406 413.
12. Polley SD, Conway DJ, Cavanagh DR, et al. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 2006 24 : 4233 4246.
13. Polley SD, Mwangi T, Kocken CH, et al. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 2004 23 : 718 728.
14. Cavanagh DR, Dodoo D, Hviid L, et al. Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infect Immun 2004 72 : 6492 6502.
15. Cavanagh DR, Elhassan IM, Roper C, et al. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol 1998 161 : 347 359.
16. Okenu DM, Riley EM, Bickle QD, et al. Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum. Infect Immun 2000 68 : 5559 5566.
17. Shi YP, Sayed U, Qari SH, et al. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect Immun 1996 64 : 2716 2723.
18. Metzger WG, Okenu DM, Cavanagh DR, et al. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunol 2003 25 : 307 312.
19. Aubouy A, Migot-Nabias F Deloron P. Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria. Infect Genet Evol 2007 7 : 147 154.
20. Aucan C, Traore Y, Tall F, et al. High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. Infect Immun 2000 68 : 1252 1258.
21. Dodoo D, Aikins A, Kusi KA, et al. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar J 2008 7 : 142.
22. Lusingu JP, Vestergaard LS, Alifrangis M, et al. Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission. Malar J 2005 4 : 48.
23. Ndungu FM, Bull PC, Ross A, Lowe BS, Kabiru E Marsh K. Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol 2002 24 : 77 82.
24. Nebie I, Diarra A, Ouedraogo A, et al. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infect Immun 2008 76 : 759 766.
25. Osier FH, Fegan G, Polley SD, et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 2008 76 : 2240 2248.
26. Roussilhon C, Oeuvray C, Muller-Graf C, et al. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med 2007 4 : e320.
27. Singh S, Soe S, Mejia J-P, et al. Identification of a conserved region of Plasmodium falciparum MSP3 targetted by biologically active antibodies to improve vaccine design. J Infect Dis 2004 190 : 1010 1018.
28. Soe S, Theisen M, Roussilhon C, Aye KS Druilhe P. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infect Immun 2004 72 : 247 252.
29. Toure FS, Deloron P Migot-Nabias F. Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum. Clin Med Res 2006 4 : 1 6.
30. Iriemenam NC, Khirelsied AH, Nasr A, et al. Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan. Vaccine 2009 27 : 62 71.
31. Stanisic DI, Richards JS, McCallum FJ, et al. Immunoglobin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitaemia and protection from symptomatic illness. Infect Immun 2009 77 : 1165 1174.
32. Dodoo D, Theander TG, Kurtzhals JA, et al. Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria. Infect Immun 1999 67 : 2131 2137.
33. Bouharoun-Tayoun H Druilhe P. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 1992 60 : 1473 1481.
34. Deloron P, Dubois B, Le Hesran JY, et al. Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of infection. Clin Exp Immunol 1997 110 : 212 218.
35. Groux H Gysin J. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Res Immunol 1990 141 : 529 542.
36. Aribot G, Rogier C, Sarthou JL, et al. Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, West Africa). Am J Trop Med Hyg 1996 54 : 449 457.
37. Polley SD, Tetteh KK, Lloyd JM, et al. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. J Infect Dis 2007 195 : 279 287.
38. Cavanagh DR, Dobano C, Elhassan IM, et al. Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect Immun 2001 69 : 1207 1211.
39. Tongren JE, Drakeley CJ, McDonald SLR, et al. Target antigen, age, duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria. Infect Immun 2006 74 : 257 264.
40. Eisen DP, Wang L, Jouin H, et al. Antibodies elicited in adults by a primary Plasmodium falciparum blood stage infection recognize different epitopes compared with immune individuals. Malar J 2007 6 : 86.
41. Ceesay SJ, Casals-Pascual C, Erskine J, et al. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 2008 372 : 1545 1554.
42. Dutta S, Lalitha PV, Ware LA, et al. Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli. Infect Immun 2002 70 : 3101 3110.
43. Burghaus PA Holder AA. Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol Biochem Parasitol 1994 64 : 165 169.
44. Polley SD, Conway DJ, Cavanagh DR, et al. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 2006 24 : 4233 4246.
45. Taylor RR, Smith DB, Robinson VJ, McBride JS Riley EM. Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass. Infect Immun 1995 63 : 4382 4388.
46. Osier FH, Polley SD, Mwangi T, Lowe B, Conway DJ Marsh K. Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3. Parasite Immunol 2007 29 : 387 394.
47. Greenwood BM, Bradley AK, Greenwood AM, et al. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg 1987 81 : 478 486.
48. Akpogheneta OJ, Duah NO, Tetteh KK, et al. Duration of naturally acquired antibody responses to blood stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun 2008 76 : 1748 1755.
49. Tongren JE, Corran PH, Jarra W, Langhorne J Riley EM. Epitope-specific regulation of immunoglobulin class switching in mice immunized with malarial merozoite surface proteins. Infect Immun 2005 73 : 8119 8129.